TABLE 1.

Baseline characteristics of the macaques in the present study

Animal	Treatment group	MHC I
4890	ART-auranofin-BSO	Mamu A*02*, Mamu B*17*
P157	ART-auranofin-BSO	Mamu A*11*
4416	ART-auranofin	Mamu A*02*
P185	ART-auranofin	Mamu B*04*
P252	ART-BSO	Mamu A*02*, Mamu B*03*
P177	ART-auranofin + ART at rebound	Mamu A*01*, Mamu B*01*